Gene therapy startup raises $55M, plans to add jobs in Triangle Date Published: December 16, 2020 DURHAM – Atsena Therapeutics, a gene therapy startup backed by Durham-based Hatteras Ventures, has $55 million in new funding and…
Gene editing firm Locus Biosciences adds another $7M to its 2020 cash haul Date Published: November 9, 2020 MORRISVILLE – Gene editing startup Locus Biosciences has landed another $7 million in new cash, adding to a year that…
Inside the $4B AskBio deal, the third largest buyout ever for an NC bioscience firm Date Published: October 27, 2020 RESEARCH TRIANGLE PARK – Asklepios BioPharmaceutical (AskBio), a pioneering gene therapy company born in Chapel Hill 19 years ago and…
Gene editing shows promise as tool to fight neuro disorder in babies, UNC study finds Date Published: October 23, 2020 CHAPEL HILL – Babies born with a faulty maternal copy of the UBE3A gene will develop Angelman syndrome, a severe…
Hatteras, one of the Triangle’s most important biotech investors, raises more than $137M Date Published: October 16, 2020 Hatteras Venture Partners, one of the Triangle’s most important biotechnology investors, has raised more $137 million for its newest fund,…
Triangle gene editing firm Locus lands $77M to support new antibacterial treatment Date Published: October 1, 2020 RESEARCH TRIANGLE PARK – Morrisville-based Locus Biosciences just got a $77 million shot in the arm to develop its new…
Durham firm extends cancer-focused collaboration with a global pharma Date Published: September 18, 2020 A Triangle gene therapy company is adding more cancer targets to its sights through a partnership with a global pharmaceutical…
Backstory: A look at RTP’s growing gene therapy hub as startup brings 200+ $102,000 jobs to Durham Date Published: August 12, 2020 RESEARCH TRIANGLE PARK – A young Boston-area gene therapy company, Beam Therapeutics, has joined a cluster of gene and cell…
Beam Therapeutics to build $83M manufacturing facility in RTP, create hundreds of jobs Date Published: August 12, 2020 RALEIGH — Beam Therapeutics, a Boston-based biotechnology company developing precision medicines through DNA base editing, plans to build a $83…